Specificity Testing of Antibody and CAR-T Cell Therapies for IND Using the Membrane Proteome Array

In this GEN webinar, our panelists will discuss their experiences using the MPA to rapidly identify potential off-target interactions, resulting in successful IND filings for CAR-T cell therapies where conventional approaches did not suffice.

Related Keywords

Donald Siegel ,Rachel Fong ,Darshil Patel ,Division Of Transfusion Medicine Therapeutic Pathology ,Preclinical Research ,Perelman School Of Medicine ,University Of Pennsylvania ,Drug Development Tool ,Pathology Laboratory Medicine ,Laboratory Medicine Director ,Transfusion Medicine ,Therapeutic Pathology Director ,Advanced Cellular ,Integral Molecular ,Membrane Proteome Array ,Drug Development ,